Immunitybio Inc is trading at $7.27 (+5.06%) as the stock rebounds alongside a broader recovery in U.S. equity markets.
- The upward move aligns with gains in the S&P 500 and Nasdaq as investor risk appetite improves following reports of geopolitical de-escalation.
- No major company-specific announcements or regulatory filings were identified, suggesting the price action is primarily driven by improved macro sentiment.